Each fixture has two Care222 far-UVC excimer lamps with patented filters that significantly reduce surface and airborne pathogens like the SARS-CoV-2 coronavirus that causes COVID-19. Leasing Options Available Enquire to PRE-Order Now *Design subject to change, image based on prototype model
Christie® CounterAct™ fixtures contain patented Care222 lamps that emit filtered far-UVC light that has been shown in the lab to inactivate more than 99.7% of airborne and surface pathogens. These fixtures may be used in occupied spaces where humans are present. This is because, unlike other UVC products, Care222 technology and proprietary filters emit only far-UVC 222nm light. This wavelength of UVC cannot penetrate human skin or eye surface water.
The patented far-UVC light that Care222 technology emits can kill all known pathogens—including coronaviruses like SARS-CoV-2, influenza, bacteria, and even antibiotic-resistant superbugs. It does this by destroying the DNA and RNA of the pathogens.
These fixtures should be used in combination with other measures like washing hands. Government and local guidelines should be followed.
There is a three step process to buying and installing CounterAct:
Step 1 - Contact us HERE and express an interest in the product.
Step 2 - We will send you further details and a questionnaire to complete to learn more about your venue and assess your requirements.
Step 3 - After we have reviewed your questionnaire, we will be touch to arrange a call with one of our consultants or to arrange a site survey if necessary.